Are prescription weight loss medications like Wegovy better than natural lifestyle changes for breaking through a PCOS weight loss plateau?
Download run
Fan-out diagram
The searches the AI actually ran for this prompt.
SEED QUERY
Are prescription weight loss medications like Wegovy better than natural lifestyle changes for breaking through a PCOS weight loss plateau?
3 real searches · 1 real-search pass
2023 international evidence-based guideline PCOS GLP-1 receptor agonists semaglutide lifestyle weight management recommendationsGoogle ↗
OBSERVED
semaglutide obesity trial STEP 1 weight loss lifestyle intervention 68 weeks NEJMGoogle ↗
OBSERVED
PCOS semaglutide randomized trial weight loss systematic review GLP-1 receptor agonist 2024Google ↗
OBSERVED
Badge and edge weight = share of passes that produced the query. Hover a query for its intent and routing format.
Query classes
Google's semantic query class for every sub-query: what kind of answer each search is after, simulated vs real.
Classifying 3 queries…
Searches and sources
ChatGPT3 real searches · gpt-6
2023 international evidence-based guideline PCOS GLP-1 receptor agonists semaglutide lifestyle weight management recommendations Google ↗
semaglutide obesity trial STEP 1 weight loss lifestyle intervention 68 weeks NEJM Google ↗
PCOS semaglutide randomized trial weight loss systematic review GLP-1 receptor agonist 2024 Google ↗
- Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome · pmc.ncbi.nlm.nih.gov
- Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome · pmc.ncbi.nlm.nih.gov
- GLP-1 receptor agonist treatment in women with polycystic ovary syndrome-a systematic review and meta-analysis · pubmed.ncbi.nlm.nih.gov
- Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome‡ | Human Reproduction · academic.oup.com
- Approval Label_215256s033lbl.pdf · accessdata.fda.gov
- Prescribing Information · wegovy.com
Queries
3 queries · click a column to sort
| Query / type | Search | Intent | Query class | Routing format | Cluster | Freq ↓ | Weight |
|---|---|---|---|---|---|---|---|
2023 international evidence-based guideline PCOS GLP-1 receptor agonists semaglutide lifestyle weight management recommendations OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 | |
semaglutide obesity trial STEP 1 weight loss lifestyle intervention 68 weeks NEJM OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 | |
PCOS semaglutide randomized trial weight loss systematic review GLP-1 receptor agonist 2024 OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 |